助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   placebo group 的翻译结果: 查询用时:0.209秒
图标索引 在分类学科中查询
所有学科
内分泌腺及全身性疾病
心血管系统疾病
中医学
消化系统疾病
精神病学
感染性疾病及传染病
急救医学
军事医学与卫生
更多类别查询

图标索引 历史查询
 

placebo group     
相关语句
  安慰剂组
     NO content of placebo group was lower than those of the other groups (39.0±9.5 μmol/L vs 62.8±8.9 μmol/L, 56.7±10.3 μmol/L, 51.5±9.3 μmol/L, P<0.05 or P<0.01);
     一氧化氮含量安慰剂组明显低于其它三组(39.0±9.5μmol/L比62.8±8.9μmol/L、56.7±10.3μmol/L和51.5±9.3μmol/L,P<0.05或P<0.01);
短句来源
     the ratio of aortic plaque area to total intima area of placebo group was higher than others (46.4%±9.3% vs 20.6% ±5.3%, 22.7%±4.6%, 28.5%±13.8%, P<0.01).
     主动脉斑块占内膜面积百分比安慰剂组高于其它三组(46.4%±9.3%比20.6%±5.3%、22.7%±4.6%和28.5%±13.8%,P<0.01)。
短句来源
     and AngⅡ of placebo group was higher than that of group with low level testosterone (687.2±36.5 ng/L vs 624.5±54.5 ng/L, P<0.05);
     血管紧张素Ⅱ含量安慰剂组高于低睾酮组(687.2±36.5ng/L比624.5±54.5ng/L,P<0.05);
短句来源
     ET of placebo group was higher than that of group with low level testosterone (911.9±15.4 ng/L vs 846.1±43.0 ng/L, P<0.05);
     内皮素含量安慰剂组高于低睾酮组(911.9±15.4ng/L比846.1±43.0ng/L,P<0.05);
短句来源
     PAI of placebo group was higher than that of group with low level testosterone (567.3±53.4 u/L vs 334.4±51.3 u/L, P<0.01);
     纤溶酶原激活物抑制物活性安慰剂组高于低睾酮组(567.3±53.4u/L比334.4±51.3u/L,P<0.01);
短句来源
更多       
  对照组
     There was no significant difference in prevention of the early ARMD between the oral zinc and antioxidant group(88.2%) and the placebo group(82.9%)(χ2=0.85,P >0.05).
     抑制早期ARMD进展有效率为88.2%与对照组82.9%比较差异无统计学意义(χ2=0.85,P>0.05)。
短句来源
     RESULTS:The effective rate against the severity of advanced ARMD was 82.3%in the oral zinc and antioxidant group,higher than in the placebo group(72.6%)(χ2=4.41,P< 0.05).
     结果:联合口服锌和抗氧化剂组抑制中晚期ARMD进展有效率为82.3%,高于对照组72.6%(χ2=4.41,P<0.05);
短句来源
     Results The clinical efficacy rates of 0.1%, 0.03% tacrolimus and the placebo group in adult patients were 100%, 80.0%, 26.7%.
     结果成人他克莫司软膏0.1%组、0.03%组和对照组的有效率分别为100%,80.0%和26.7%;
短句来源
     Results: The overall incidence of postoperative AF(paroxysmal and persistent) was significantly higher in the placebo group compared with the amiodarone group(32.2% vs 6.4%,P<0.01,OR=7.0).
     结果:对照组术后AF总发生率明显高于实验组(32.2%vs6.4%,P<0.01,OR=7.0)。
短句来源
     all levels of TG,TC, LDL-C decreased ( P <0.05), HDL-C level increased ( P < 0.05), compared with placebo group.
     血脂中TG、TC、 LDL-C水平降低(P<0.05)、HDL-C水平升高(P<0.05),与对照组比较差异均有显著性。
更多       
  安慰剂对照组
     There were 11 patients in Azithromyosin group(with a converting ratio of 81.8%) while there were 10 patients in placebo group(with a converting ratio of(50.0%)) with a significant difference between the two groups(P<0.01).
     阿奇霉素治疗组11例,治疗后MP抗体IgG转阴率为81.8%(9/11),安慰剂对照组10例,治疗后转阴率为50.0%(5/10),两组比较差异有显著性(P<0.01)。
短句来源
     RESULTS:As-IgG,as-IgG subclass and as-IgE were measured in this paper and showed that the level of as-IgG,as-IgG 1,as-IgG 4 increased, but no statistically significance whereas on change was found in placebo group.
     结果:As-IgG、as-IgG1、as-IgG4均有升高,但与安慰剂对照组比较,差异不显著。
短句来源
     Then the patients were randomly divided into two groups:the placebo group and the Azithromyosin group.
     90例冠心病患者中血MP抗体IgG阳性的患者,随机分为二组:安慰剂对照组和阿奇霉素治疗组。
短句来源
     Results The significant improvement of parkinsonian symptoms was found in selegiline-added group and placebo group compared to Webster scale with pre- and post-treatmetnt (P<0.05 and P<0.01), but the effect in selegiline-added group was superior over the placebo group (P<0.01).
     结果 司来吉兰治疗组治疗前后自身对照Webster评分有明显改善(P<0.05或P<0.01),安慰剂对照组于治疗后第4,6周差异有显著性意义(P<0.05或p<0.01),司来吉兰组疗效优于安慰剂组(P<0.01);
短句来源
     COPD exacerbation times were reduced in 814 treated group (2.7 ±2.1 per year) , compared with placebo group (4.8± 1.9 per year) . The difference between two group is significanf (P< 0.05) . The annual rate of decline in FEV1 was lower in 814 treated group than in placebo group.
     COPD病情急性加重的发生次数:814治疗组中的COPD患者平均每年每个患者发生2.7±2.1次病情急性加重,而安慰剂对照组中平均每年每个患者发生4.8±1.9次病情急性加重,经统计学处理,两组间有显著性差异(P<0.05)。
短句来源
更多       
  安慰剂组间
     Heart rate in the infarct inderal group was significantly decreased as compared with that of infarct placebo group [(153±6.36) min -1 vs (225±4.08) min -1 , P <0.001], but there was no significant difference in left ventricular end diastolic pressure, +dp/dt max and cardiac index between the two groups.
     而与心梗 -安慰剂组间无显著差异。 心梗 -心得安组与心梗 -安慰剂组比较 ,心率显著降低 [(15 3± 6 .36 ) min- 1 vs(2 2 5± 4.0 8) m in- 1 ,P<0 .0 0 1) ],但左室舒张末压、 +dp/ dtmax和心脏指数两组间无显著差异。
短句来源
     There was significant difference between whether undergoing psychotherapy or not whereas no significant difference between drug treatment group and placebo group.
     药物治疗组和安慰剂组间疗效无显著差别。 而是否用心理治疗则有显著差异。
短句来源
     The results showed that in children with sodium sensitivity, the rising of blood pressure in the supplementary group was lower by 0.58/0.59kPa (4.3/4.8mmHg) than that in placebo group (P<005), while no significant change was found between supplemenltay group and placebo group in children with nonsodium sensitivity.
     结果显示:盐敏感性儿童,补钾补钙组2年期血压增长值较安慰剂组低4.3/4.8mmHg(P<0.05),前者血压增长幅度较后者低3.6/7.0个百分点(P<0.05); 而盐不敏感儿童,补充组与安慰剂组间血压变化无显著性差异。
短句来源
     \ Results\ 86.9% of paitients received ONT, 62.2% VNT, 23.4%β BK, 74.5% ASP, 55.2% CAA, 34.8% FDS. The characteristics of patients in captopril group and placebo group with OMT,VNT,β BK,ASP,CAA,FDS were similar.
     结果在中国心脏研究—I试验中,口服硝酸酯使用率为86.9%,静脉硝酸盐为62.2%,β-阻滞剂为23.4%,阿斯匹林为74.5%,钙拮抗剂为55.2%,复方丹参注射液为34.8%.在以上6种并用药中,卡托普利与安慰剂组间病人基础临床特征均相似。
短句来源
     Result:By statistical analysis,serum IgE value,BALF leukocyte count,eosinophil rate in differential count,eosinophil and lymphocyte count around bronchial wall have significant differences while each imiquimod therapeutic group compared with control group or placebo group(t test,u test,P<0 05),but lymphocyte rate in differential count has no significant difference among imiquimod therapeutic groups, positive group and placebo group(u test,P>0 05).
     结果 :咪喹莫特治疗组外周血IgE值 ,BALF细胞计数、EOS分类及 0 1~ 0 3mm支气管周围EOS计数、L计数与对照组间或安慰剂组间有统计学意义 (P <0 0 5 ) ,而BALFL分类百分比 ,治疗组与对照组间或安慰剂组间无统计学意义。
短句来源

 

查询“placebo group”译词为其他词的双语例句

     

    查询“placebo group”译词为用户自定义的双语例句

        我想查看译文中含有:的双语例句
    例句
    为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
      placebo group
    There were no significant differences in the other vestibular functional indices between the modafinil group and placebo group.
          
    Non-enriched beverage was given to the placebo group.
          
    TAP expression increased after exercise mainly in the neutrophils of the placebo group.
          
    Plasma malondialdehyde only increased in the placebo group after exercise.
          
    During a high-altitude expedition in the Himalayas, protection was shown to be significantly better in the supplemented group than in the placebo group, as determined by anaerobic threshold and pentane exhalation.
          
    更多          


    219 cases of angina pectoris were treated with crataegus pinnatifida (CP) and 29 controls, with placebo. The antianginal effectiveness of CP was as follows: 31.6% of patients with markedimprovement, 60.6% with improvement, 5.8% without improvement, and 2% even becoming worse. In 157 cases, 7.6% were rated: as having marked improvement in ECG versus 39.5% with moderate improvement, 51. 6% without change and 1.3% with adverse reaction. Among 138 nitroglycerine dependent patients, 55% have broken off in the intake...

    219 cases of angina pectoris were treated with crataegus pinnatifida (CP) and 29 controls, with placebo. The antianginal effectiveness of CP was as follows: 31.6% of patients with markedimprovement, 60.6% with improvement, 5.8% without improvement, and 2% even becoming worse. In 157 cases, 7.6% were rated: as having marked improvement in ECG versus 39.5% with moderate improvement, 51. 6% without change and 1.3% with adverse reaction. Among 138 nitroglycerine dependent patients, 55% have broken off in the intake of nitroglycerine versus 30% with decrease of the dose, 9.4% taking as usual and 6.3% even with increased doses. The result of placebo group was worse than that of the investigative group.

    用国产山楂酮治疗冠心病心绞痛219例,安慰剂对照组29例,心绞痛显效65例(31.6%)。有效125例(60.6%),无效12例(5.8%),加重4例(2%)。心电图显效12例(7.6%)有效62例(39.5%),无改变81例(51.6%),加重2例(1.3%),硝酸甘油停用76例(55%),减量40例(30%),无变化13例(9.4%),加重9例(6.5%),安慰剂对照组,心绞痛显效2例(4.4%),有效15例(32.2%),总有效率36.6%,心电图仅1例有改善,总有效率3.3%。

    This paper summarizes the results the treatment of 100 cases with infectious allergic arthritis with alpha-Polyantigen and its etiologic analysis. After treatment in 90.48% of patients the joints swelling and pain subsided in 1-10 days; ESR, alpha-2, gama-globulin, C-3 decreased ( p < 0.001 ); ASO and CIC decreased (respectively P < 0.05 and 0.005 ); serum electrophoresi A and IgA increased (respectively p < 0.001 and 0.005). After 6 months to 4 years of follow-up the cure rate for the alpha-Polyantigen group...

    This paper summarizes the results the treatment of 100 cases with infectious allergic arthritis with alpha-Polyantigen and its etiologic analysis. After treatment in 90.48% of patients the joints swelling and pain subsided in 1-10 days; ESR, alpha-2, gama-globulin, C-3 decreased ( p < 0.001 ); ASO and CIC decreased (respectively P < 0.05 and 0.005 ); serum electrophoresi A and IgA increased (respectively p < 0.001 and 0.005). After 6 months to 4 years of follow-up the cure rate for the alpha-Polyantigen group (100 cases )was 84%, as compared with the placebo group ( 20 cases ) in which 95% of cases did not respond ( p < 0.05 ), with the Chloroquine-Tndocin group ( cure rate: 60.67% p < 0.005 ) and with the tonsillecto- mic group(cure rate: 37.5%; p<0.005). According to HLA in 20 cases there were 55% of cases with positive HLA-B-7 antigen, as compared with the control group ( 7.14%; p < 0.005) , howing that there is significant difference. The results show that alpha-polyantigen has nti-inflammatory and anti-allergic actions, by which the diagnosis of child growth-pain can be made and the etiology of the disease explored.

    本题总结了100例感染过敏性关节炎的多抗甲素治疗及其病因学探讨的结果。随访观察六个月至四年,多抗甲素组(100例)治愈率84%;安慰剂对照组(20例)5%减轻,两组比较结果,P<0.005。并观测HLA20例、HLAB-7抗原阳性者55%,与对照组(7.14%)相比较,P<0.005,有统计学意义。本题探讨结果表明,多抗甲素具育抗炎、抗过敏、鉴别小儿生长痛和佐证说明本病病因学的作用。

    This paper reports the results of 15 cases of chronic hepatitis B treated with alpha-inter -feron (α-IFN) combined with silybum marinanum compound at a small dose (α-IFN 5000 units/day)in a long treatment course(3-6 months). The cure rate was 66.6% in the treatment group and 33.3% in the placebo group. The amount of α-IFN in the serum of the patients was determined before and after treatment, but no α-IFN in the serum was detected before treatment, α-IFN elevated to 5-40 units/ml after treatment for 3-7...

    This paper reports the results of 15 cases of chronic hepatitis B treated with alpha-inter -feron (α-IFN) combined with silybum marinanum compound at a small dose (α-IFN 5000 units/day)in a long treatment course(3-6 months). The cure rate was 66.6% in the treatment group and 33.3% in the placebo group. The amount of α-IFN in the serum of the patients was determined before and after treatment, but no α-IFN in the serum was detected before treatment, α-IFN elevated to 5-40 units/ml after treatment for 3-7 months. However, it would drop when the treatment was stopped. The therapeutic effect was remarkable when the amount of α-IFN in the serum was increased. The results indicate that the anti-viral drug(IFN)combined with silyoum marinanum compound may be used to cure chronic hepatitis B.

    本文报告人白细胞干扰素联合复方水飞蓟蜜丸治疗乙型慢性肝炎15例,采用小剂量(干扰素5万μ/日)长疗程(3~6个月)疗法,乙型肝炎血清标志物在15例中有10例出现有效指标,有效率达66.6%;对照组有效者5例,无效者10例,有效率33.3%,二者相比,有一定差异,但因病例少,差异不显著(P>0.05)。干扰素治疗前后曾检测血中干扰素含量,治疗前血中均测不出,治疗后3~7个月,血中干扰素量可达5~40μ/ml,停药后干扰素含量下降。用药后血中干扰素量明显增高者,疗效好,本文说明抗病毒药联合保肝药治疗乙型肝炎有一定作用,但仍需进一步观察。

     
    << 更多相关文摘    
    图标索引 相关查询

     


     
    CNKI小工具
    在英文学术搜索中查有关placebo group的内容
    在知识搜索中查有关placebo group的内容
    在数字搜索中查有关placebo group的内容
    在概念知识元中查有关placebo group的内容
    在学术趋势中查有关placebo group的内容
     
     

    CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
    版权图标  2008 CNKI-中国知网
    京ICP证040431号 互联网出版许可证 新出网证(京)字008号
    北京市公安局海淀分局 备案号:110 1081725
    版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社